Table 3 -.
Unadjusted and adjusted Fine-Gray models assessing risk of graft loss in AAs during the first four years post-transplant*
| Variable | Unadjusted Year 1 SDHR (95% CI) |
Adjusted Year 1 SDHR (95% CI) |
Unadjusted Year 2 SDHR (95% CI) |
Adjusted Year 2 SDHR (95% CI) |
Unadjusted Year 3 SDHR (95% CI) |
Adjusted Year 3 SDHR (95% CI) |
Unadjusted Year 4 SDHR (95% CI) |
Adjusted Year 4 SDHR (95% CI) |
|---|---|---|---|---|---|---|---|---|
| African-American | 1.56 (1.09–2.23) |
1.54 (1.07–2.22) |
1.78 (0.92–3.44) |
1.56 (0.79–3.07) |
1.50 (0.66–3.40) |
1.08 (0.46–2.53) |
2.52 (1.04–6.11) |
1.80 (0.73–4.46) |
| Acute Rejection | -- | 2.32 (1.30–4.12) |
-- | 54.39 (1.48–13.1) |
-- | 6.78 (1.45–31.7) |
-- | 8.84 (2.01–38.9) |
| Mean Glucose >160 mg/dL | -- | 1.04 (0.69–1.56) |
-- | 1.18 (0.61–2.30) |
-- | 3.25 (1.50–7.06) |
-- | 1.87 (0.91–3.83) |
| Mean SBP >140 mmHg | -- | 0.95 (0.67–1.36) |
-- | 1.07 (0.59–1.94) |
-- | 1.56 (0.69–3.50) |
-- | 1.88 (0.93–3.78) |
| Mean Tacrolimus CV >40% | -- | 1.28 (0.90–1.82) |
-- | 1.72 (0.89–3.32) |
-- | 4.13 (1.99–8.57) |
-- | 1.74 (0.80–3.78) |
| Mean Hemoglobin <10 gm/dL | -- | 1.23 (0.84–1.81) |
-- | 1.99 (0.79–5.04) |
-- | 3.27 (1.06–10.0) |
-- | 1.42 (0.40–5.04) |
*
All statistical assessments for determining the significance of parameter estimates were made using the chi square test statistic in both unadjusted and fully adjusted models